175 related articles for article (PubMed ID: 2904525)
21. [Evaluation of the therapeutic effect of flumazenil in hepatic encephalopathy using cerebral cartography].
Bello Mimbrera G; García de León M; de la Torre Gutiérrez S; Montero Vázquez J; Torres Salcines J; de la Torre Fernández JM
Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):277-9. PubMed ID: 2499914
[TBL] [Abstract][Full Text] [Related]
22. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
Cadranel JF; el Younsi M; Pidoux B; Zylberberg P; Benhamou Y; Valla D; Opolon P
Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):325-9. PubMed ID: 7600138
[TBL] [Abstract][Full Text] [Related]
23. Flumazenil in the treatment of hepatic encephalopathy in children with fulminant liver failure.
Devictor D; Tahiri C; Lanchier C; Navelet Y; Durand P; Rousset A
Intensive Care Med; 1995 Mar; 21(3):253-6. PubMed ID: 7790615
[TBL] [Abstract][Full Text] [Related]
24. [The use of flumazenil in the treatment of hepatic encephalopathy secondary to acute liver failure. A report of 2 cases].
Díaz de León-Ponce M; Eid-Lidt G; Castañón-González JA; Deseaño-Estudillo JL; Reyes B
Gac Med Mex; 1993; 129(5):347-50. PubMed ID: 7926421
[No Abstract] [Full Text] [Related]
25. [Flumazenil, hepatic encephalopathy and benzodiazepines].
Sacristán JA; Soto J; Francis D; Sánchez R
Med Clin (Barc); 1991 Mar; 96(8):317. PubMed ID: 1645830
[No Abstract] [Full Text] [Related]
26. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study.
Barbaro G; Di Lorenzo G; Soldini M; Marziali M; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Barbarini G
Eur J Emerg Med; 1998 Jun; 5(2):213-8. PubMed ID: 9846248
[TBL] [Abstract][Full Text] [Related]
27. Improvement of chronic hepatic encephalopathy in dogs by the benzodiazepine-receptor partial inverse agonist sarmazenil, but not by the antagonist flumazenil.
Meyer HP; Legemate DA; van den Brom W; Rothuizen J
Metab Brain Dis; 1998 Sep; 13(3):241-51. PubMed ID: 9804368
[TBL] [Abstract][Full Text] [Related]
28. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Barbarini G
Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
[TBL] [Abstract][Full Text] [Related]
29. The efficacy of flumazenil in subclinical to mild hepatic encephalopathic ambulatory patients. A prospective, randomised, double-blind, placebo-controlled study.
Dursun M; Caliskan M; Canoruc F; Aluclu U; Canoruc N; Tuzcu A; Yilmaz S; Isikdogan A; Ertem M
Swiss Med Wkly; 2003 Feb; 133(7-8):118-23. PubMed ID: 12644958
[TBL] [Abstract][Full Text] [Related]
30. Effect of flumazenil in hepatic encephalopathy.
Grimm G; Katzenschlager R; Holzner F; Ferenci P; Schneeweiss B; Laggner A; Lenz K; Druml W; Madl C
Eur J Anaesthesiol Suppl; 1988; 2():147-9. PubMed ID: 2842131
[No Abstract] [Full Text] [Related]
31. [GABA-benzodiazepine receptor complex: therapeutic role of benzodiazepine antagonists].
Andresen M; Arrese M; Dougnac A; Godoy J; Prat G; Chianale J
Rev Med Chil; 1989 Aug; 117(8):944-6. PubMed ID: 2562414
[No Abstract] [Full Text] [Related]
32. Reversal of hepatic coma with flumazenil with improvement in visual evoked potentials.
Burke DA; Mitchell KW; al Mardini H; Record CO
Lancet; 1988 Aug; 2(8609):505-6. PubMed ID: 2900422
[No Abstract] [Full Text] [Related]
33. [Chronic hepatic encephalopathy treated by long-term intravenous administration of flumazenil in ambulatory care].
Péroux JL; Paolini O; Tran A; Frappa B; Rampal P
Gastroenterol Clin Biol; 1996 Feb; 20(1):106-8. PubMed ID: 8734316
[TBL] [Abstract][Full Text] [Related]
34. Flumazenil in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double blind randomized placebo controlled study.
Laccetti M; Manes G; Uomo G; Lioniello M; Rabitti PG; Balzano A
Dig Liver Dis; 2000 May; 32(4):335-8. PubMed ID: 11515632
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomised, placebo controlled multicentre study.
Gyr K; Meier R; Häussler J; Boulétreau P; Fleig WE; Gatta A; Holstege A; Pomier-Layrargues G; Schalm SW; Groeneweg M; Scollo-Lavizzari G; Ventura E; Zeneroli ML; Williams R; Yoo Y; Amrein R
Gut; 1996 Aug; 39(2):319-24. PubMed ID: 8977350
[TBL] [Abstract][Full Text] [Related]
36. Persisting benzodiazepine metabolites responsible for the reaction to the benzodiazepine antagonist flumazenil in patients with hepatic encephalopathy.
Meier R; Gyr K; Scholer A
Gastroenterology; 1991 Jul; 101(1):274-5. PubMed ID: 2044919
[No Abstract] [Full Text] [Related]
37. [Treatment of hepatic encephalopathy with flumazenil].
Marsepoil T; Hermant JL; Ho P; Blin F; Levesque P
Ann Fr Anesth Reanim; 1990; 9(4):399-400. PubMed ID: 2119158
[No Abstract] [Full Text] [Related]
38. Effect of flumazenil on the electroencephalogram of patients with portosystemic encephalopathy. Results of a double blind, randomised, placebo-controlled multicentre trial.
Groeneweg M; Gyr K; Amrein R; Scollo-Lavizzari G; Williams R; Yoo JY; Schalm SW
Electroencephalogr Clin Neurophysiol; 1996 Jan; 98(1):29-34. PubMed ID: 8689991
[TBL] [Abstract][Full Text] [Related]
39. [Clinical pharmacology of flumazenil--a benzodiazepine receptor antagonist].
Janicki P; Rewerski W
Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1653-6. PubMed ID: 2855862
[No Abstract] [Full Text] [Related]
40. Benzodiazepine receptor ligands and the syndrome of hepatic encephalopathy.
Jones EA; Skolnick P
Prog Liver Dis; 1990; 9():345-70. PubMed ID: 2156301
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
